Clinical trials
Epilepsies, Partial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
| Recruiting | 13 |
| Terminated | 13 |
| Active, not recruiting | 5 |
| Enrolling by invitation | 3 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 11 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 6 |
| UCB Pharma | 6 |
| SK Life Science, Inc. | 5 |
| Supernus Pharmaceuticals, Inc. | 5 |
| Marinus Pharmaceuticals | 4 |
| Mayo Clinic | 4 |
| Pfizer | 4 |
| Rapport Therapeutics Inc. | 4 |
| Biohaven Therapeutics Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsies, Partial | 101 |
| Epilepsy | 55 |
| Seizures | 44 |
| Drug Resistant Epilepsy | 9 |
| Epilepsy, Temporal Lobe | 6 |
| Epilepsy, Generalized | 4 |
| Lennox Gastaut Syndrome | 3 |
| Spasms, Infantile | 2 |
| Abnormalities, Multiple | 1 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.